June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Stromal demarcation line after Cross-Linking: Sometimes invisible!
Author Affiliations & Notes
  • Louis Lhuillier
    ophtalmology, CHR Metz, Metz, France
  • Mathilde Boiché
    ophtalmology, CHR Metz, Metz, France
  • Fanny Tréchot
    ophtalmology, CHR Metz, Metz, France
  • rekia yahia
    ophtalmology, CHR Metz, Metz, France
  • Naïla HOUMAD
    ophtalmology, CHR Metz, Metz, France
  • Oualid Guechi
    ophtalmology, CHR Metz, Metz, France
  • Francois Ameloot
    ophtalmology, CHR Metz, Metz, France
  • Shanour Premy
    ophtalmology, CHR Metz, Metz, France
  • adina Agapie
    ophtalmology, CHR Metz, Metz, France
  • Jean-Marc Perone
    ophtalmology, CHR Metz, Metz, France
  • Footnotes
    Commercial Relationships Louis Lhuillier, None; Mathilde Boiché, None; Fanny Tréchot, None; rekia yahia, None; Naïla HOUMAD, None; Oualid Guechi, None; Francois Ameloot, None; Shanour Premy, None; adina Agapie, None; Jean-Marc Perone, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3001. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Louis Lhuillier, Mathilde Boiché, Fanny Tréchot, rekia yahia, Naïla HOUMAD, Oualid Guechi, Francois Ameloot, Shanour Premy, adina Agapie, Jean-Marc Perone; Stromal demarcation line after Cross-Linking: Sometimes invisible!. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3001.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate and to compare the visibility and the depth of the stromal demarcation line after corneal collagen cross-linking (CXL) using anterior segment optical coherence tomography (AS-OCT).<br />

Methods: All consecutive patients treated with CXL between march 2014 and November 2014 in CHR Metz-Thionville (Mercy Hospital) were included. They all underwent the same procedure: accelerated-CXL protocole (10 minutes UVA irradiation with 9 mW/cm intensity), irradiation device (IROC UV-X™ 2000, Medeuronet). Iso-osmolar riboflavin solution was used for corneas with thinnest pachymetry above 450 µm (before de-epithelization), hypo-osmolar solution was used for thiner corneas (400-450 µm before de-epithelization).<br /> One month after the procedure, AS-OCT examination was performed in all patients (RS-3000, NIDEK). Two independent ophthalmologists scored the visibility of the stromal demarcation line (0: not visible line; 1: visible line, but measurement not clearly defined; 2: clearly visible line). The depth of corneal demarcation line was measured at anytime it was possible.<br />

Results: Twenty-one patients (30 eyes) with progressive keratoconus were included. Mean age was 26.1 ± 8.6 years. Mean duration between the diagnosis of keratoconus and CXL was 17.2 ± 9.5 months. 22 eyes (73%) were stage 1 (thinning of epithelial and stromal layers at the conus) and 8 eyes (27%) were stage 2 (hyperreflective anomalies at the Bowman’s layer level with epithelial thickening) according to Sandali’s AS-OCT keratoconus classification. Pre-operative mean anterior Kmax was 56.8 ± 4.8 D and mean thinnest pachymetry was 451.8 ± 27.3 µm. Nine (30%) demarcation lines were scored 2, 15 (50%) were scored 1 and 6 (20%)were scored 0 (not visible). Mean depth of the corneal stromal demarcation line was 322.5 ± 41.6 μm (range 230-362 μm) according to the first ophthalmologist, and 328.1 ± 39.7 μm (range 232-367 μm) according to the second one.<br />

Conclusions: Mean depth of the corneal stromal demarcation line after CXL was 322.5 µm (first ophthalmologist) and 328.1 (second ophthalmologist). Stromal demarcation line was visible for 80% of the crosslinked corneas. A long term follow-up will be interesting to assess whether or not it is associated with a decreased efficiency of the procedure.<br />

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×